Today, the global nutraceutical industry is growing at a rapid pace, from $400 billion in 2020 to an anticipated $720 billion by 2027. The increasing popularity of nutraceuticals is driven primarily through a lifestyle shift to the prevention rather than treatment of illness. More and more people are realizing the need for supplements, vitamins, superfoods, sports nutrition, and functional foods and beverages.

Despite its remarkable growth, however, the nutraceutical industry is highly fragmented with a substantial pool of prospective acquisitions.

Smart for Life acquires target companies utilizing a combination of cash, seller notes, earnouts, and stock, with the typical cash portion ranging from 40% to 60% of the transaction. This approach offers distinct benefits to the stakeholders of the acquired companies in the form of a significant liquidity event and a material equity position in a Nasdaq-listed public company. The management of the acquired companies are also able to continue their roles, leading growth and driving innovation with access to the resources and opportunities available as part of a larger, multifaceted organization.

Through its five companies, Smart for Life boasts a dynamic, exciting mix of brands and capabilities. Its current businesses include contract manufacturing, consumer brands, digital marketing services, and licensing agreements. 

The Company offers a variety of cutting-edge formulary and manufacturing capabilities including capsules, tablets, powders, health bars, baked goods, functional foods, and other product types and delivery methods.